| Literature DB >> 32522283 |
Shuhua Shen1, Chao Li2, Luwei Xiao1, Xiaoming Wang1, Hang Lv3, Yuan Shi3, Yixue Li4,5, Qi Huang6.
Abstract
BACKGROUND: Genetic research on longevity has provided important insights into the mechanism of aging and aging-related diseases. Pinpointing import genetic variants associated with aging could provide insights for aging research.Entities:
Keywords: Centenarian; Longevity; WGS
Mesh:
Year: 2020 PMID: 32522283 PMCID: PMC7285530 DOI: 10.1186/s40246-020-00271-7
Source DB: PubMed Journal: Hum Genomics ISSN: 1473-9542 Impact factor: 4.639
Characteristics of the centenarians
| Age at draw | Sex | BMI | Major age-related diseases | Race |
|---|---|---|---|---|
| 104 | Male | 22.6 | None | Eastern Asiatic Mongoloid |
| 103 | Male | 21.8 | None | Eastern Asiatic Mongoloid |
| 102 | Female | 20.6 | None | Eastern Asiatic Mongoloid |
| 105 | Female | 19.8 | None | Eastern Asiatic Mongoloid |
| 116 | Female | 27.2 | None | Eastern Asiatic Mongoloid |
| 101 | Female | 22.4 | None | Eastern Asiatic Mongoloid |
| 102 | Female | 20.6 | None | Eastern Asiatic Mongoloid |
| 104 | Male | 18.6 | None | Eastern Asiatic Mongoloid |
| 103 | Male | 21.5 | None | Eastern Asiatic Mongoloid |
| 103 | Female | 20.3 | None | Eastern Asiatic Mongoloid |
| 101 | Male | 24.5 | None | Eastern Asiatic Mongoloid |
| 105 | Female | 22.5 | None | Eastern Asiatic Mongoloid |
| 103 | Male | 21.6 | None | Eastern Asiatic Mongoloid |
| 104 | Female | 20.7 | None | Eastern Asiatic Mongoloid |
| 102 | Female | 19.8 | None | Eastern Asiatic Mongoloid |
| 100 | Female | 22.3 | None | Eastern Asiatic Mongoloid |
| 103 | Male | 21.4 | None | Eastern Asiatic Mongoloid |
| 114 | Female | 20.6 | None | Eastern Asiatic Mongoloid |
| 100 | Male | 26.2 | None | Eastern Asiatic Mongoloid |
Fig. 1Overall design of the study. WGS were applied to 19 centenarians. Association test was used to select candidate variants/genes. Function analysis was then applied
Significantly correlated genes in SKAT analysis
| Gene | SKAT_Common.Only | SKAT_Rare.Only | SKAT_all | SKAT_Rare.pro | SKAT_Common.pro | Burden_all | Burden__Rare.pro | Burden__Common.pro |
|---|---|---|---|---|---|---|---|---|
| 1.97E−27 | 4.57E−32 | 4.41E−31 | 2.72E−48 | 2.26E−51 | 2.50E−30 | 1.46E−50 | 3.13E−51 | |
| 1.70E−27 | 6.41E−21 | 8.76E−25 | 7.30E−36 | 1.52E−45 | 8.66E−26 | 2.20E−37 | 5.57E−30 | |
| 0.03254211 | 1.57E−14 | 2.66E−13 | 0.029113904 | 4.24E−30 | 1.94E−13 | 1.33E−21 | 1.37E−20 | |
| 4.19E−07 | 1.71E−13 | 2.01E−12 | 1.13E−09 | 3.32E−32 | 5.43E−13 | 1.40E−16 | 8.32E−16 | |
| 0.351394973 | 4.20E−10 | 4.84E−07 | 0.564180913 | 3.26E−19 | 2.18E−08 | 3.17E−10 | 9.98E−11 | |
| 0.182676324 | 2.30E−09 | 3.99E−09 | 9.37E−08 | 2.84E−24 | 3.99E−06 | 9.70E−09 | 6.54E−09 | |
| 0.640011254 | 2.33E−09 | 4.68E−08 | 2.45E−08 | 3.01E−18 | 2.60E−06 | 2.54E−10 | 3.23E−10 | |
| 0.248268983 | 2.07E−08 | 6.87E−06 | 6.88E−05 | 1.99E−15 | 8.07E−07 | 1.61E−08 | 2.34E−08 | |
| 0.021102518 | 1.05E−06 | 5.24E−07 | 0.01776692 | 3.01E−12 | 8.72E−08 | 4.27E−11 | 5.39E−11 | |
| 0.479393621 | 2.95E−06 | 3.42E−06 | 5.33E−10 | 3.26E−10 | 0.001382303 | 0.000184681 | 0.000282752 |
Significantly enriched pathway
| Gene set name[#Genes(K)] | Description | #Genes in Overlap(k) | FDR | |
|---|---|---|---|---|
| REACTOME_INTERFERON_GAMMA_SIGNALING[63] | Interferon gamma signaling | 5 | 2.61E−09 | 2.81E−06 |
| KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION[89] | Antigen processing and presentation | 5 | 1.52E−08 | 8.16E−06 |
| KEGG_ALLOGRAFT_REJECTION[38] | Allograft rejection | 4 | 3.55E−08 | 1.28E−05 |
| KEGG_GRAFT_VERSUS_HOST_DISEASE[42] | Graft-versus-host disease | 4 | 5.35E−08 | 1.40E−05 |
| KEGG_TYPE_I_DIABETES_MELLITUS[44] | Type I diabetes mellitus | 4 | 6.51E−08 | 1.40E−05 |
| KEGG_CELL_ADHESION_MOLECULES_CAMS[134] | Cell adhesion molecules (CAMs) | 5 | 1.19E−07 | 2.13E−05 |
| KEGG_AUTOIMMUNE_THYROID_DISEASE[53] | Autoimmune thyroid disease | 4 | 1.40E−07 | 2.15E−05 |
| REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE[14] | Translocation of ZAP-70 to immunological synapse | 3 | 2.21E−07 | 2.97E−05 |
| REACTOME_INTERFERON_SIGNALING[159] | Interferon signaling | 5 | 2.78E−07 | 3.32E−05 |
| REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS[16] | Phosphorylation of CD3 and TCR zeta chains | 3 | 3.39E−07 | 3.66E−05 |
HLA subtype percentage in the case and control groups
| HLA type | Ratio | Control_Percentage | Case_Percentage |
|---|---|---|---|
| A*02:03 | 3.7 | 0.03 | 0.11 |
| DRB1*13:02 | 5.6 | 0.01 | 0.05 |
| DRB1*14:01 | 4.2 | 0.02 | 0.08 |
| DRB1*16:02 | 5.6 | 0.01 | 0.05 |
Fig. 2HLA typing’s correlation with the centinarian group. Frequency ratio of every HLA type was plotted. Four HLA types with frequency ratio larger than 3 were marked